Zilokem 20 Tablet contains Azilsartan medoxomil 20 mg, an angiotensin II receptor blocker (ARB) indicated for the treatment of hypertension. By selectively inhibiting the binding of angiotensin II to the AT1 receptor, Zilokem 20 effectively reduces vasoconstriction and aldosterone secretion, leading to decreased blood pressure. This antihypertensive action helps reduce the risk of cardiovascular events such as stroke and myocardial infarction in patients with elevated blood pressure. Zilokem 20 is typically administered once daily, with or without food, and dosage adjustments may be required based on patient response and tolerability. It is contraindicated in patients with known hypersensitivity to azilsartan or any component of the formulation, and caution is advised in individuals with renal impairment, hepatic dysfunction, or volume depletion. Common adverse effects include dizziness, fatigue, and hypotension, while serious adverse reactions are rare but may include hyperkalemia and renal function deterioration. Regular monitoring of blood pressure, renal function, and serum electrolytes is recommended during therapy. Zilokem 20 should not be used concomitantly with aliskiren in diabetic patients or those with renal impairment. This medication should be prescribed and used under medical supervision to ensure optimal therapeutic outcomes and patient safety.